NEWS


Belgium’s MRM Health in €55m Series B financing

Belgium-based MRM Health NV, a clinical-stage biopharmaceutical company pioneering microbiome-based therapeutics for inflammatory diseases and immune-oncology, has announced the successful closing of a €55 million…